Forge Biologics, A Member Of Ajinomoto Bio-Pharma Services, Capacity Update January 2025: Cell & Gene Therapy

Discover how Forge Biologics’ state-of-the-art, 200,000 sq. ft. facility, cutting-edge proprietary technologies, and comprehensive suite of specialized services set the standard in AAV manufacturing. Designed to support developers at every stage of their journey—from initial discovery through clinical development and ultimately to delivery—Forge’s dedicated team of experts provides tailored solutions to accelerate innovation.

With a focus on precision, scalability, and quality, our facility and services empower developers to bring their groundbreaking gene therapies to life, ensuring successful outcomes at every critical milestone.